Nomura's Takeaways From Meeting With Gilead Sciences' Management By: Benzinga via Benzinga January 16, 2015 at 10:17 AM EST Ian Somaiya of Nomura on Friday reiterated a Buy rating on shares of Gilead Sciences, Inc. (NASDAQ: GILD) with a $146 price target ... Read More >> Related Stocks: Gilead Sciences